TY - JOUR T1 - Effect of magnesium supplementation on circulating biomarkers of cardiovascular disease JF - medRxiv DO - 10.1101/2020.04.29.20083972 SP - 2020.04.29.20083972 AU - Alvaro Alonso AU - Lin Y. Chen AU - Kyle D. Rudser AU - Faye L. Norby AU - Mary R. Rooney AU - Pamela L. Lutsey Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/05/02/2020.04.29.20083972.abstract N2 - Background Magnesium supplementation may be effective for the prevention of cardiometabolic diseases, but mechanisms are unclear. Proteomic approaches can assist in identifying underlying mechanisms.Methods We collected repeated blood samples in 52 individuals enrolled in a double-blind trial which randomized participants 1:1 to oral magnesium supplementation (400 mg magnesium / day in the form of magnesium oxide) or matching placebo for 10 weeks. Plasma levels of 91 proteins were measured in baseline and follow-up samples using the Olink Cardiovascular Disease III proximity extension assay panel, and modeled as arbitrary units in log2 scale. We evaluated the effect of oral magnesium supplementation on changes in protein levels and the baseline association between serum magnesium and protein levels. The Holm procedure was used to adjust for multiple comparisons.Results Participants were 73% women, 94% white, and had a mean age of 62. Changes in proteins did not significantly differ between the two intervention groups after correction for multiple comparisons. The most statistically significant effects were on myoglobin [difference −0.319 log2 units, 95% confidence interval (CI) (−0.550, −0.088), p = 0.008], tartrate-resistant acid phosphatase type 5 [−0.187, (−0.328, −0.045), p = 0.011], tumor necrosis factor ligand superfamily member 13B [−0.181, (−0.332, −0.031), p = 0.019], ST2 protein [−0.198, (−0.363, −0.032), p =0.020], and interleukin-1 receptor type 1 [−0.144, (−0.273, −0.015), p = 0.029]. Similarly, none of the associations of baseline serum magnesium with protein levels were significant after correction for multiple comparisons.Conclusion Though we did not identify statistically significant effects of oral magnesium supplementation in this relatively small study, this study demonstrates the value of proteomic approaches for the investigation of mechanisms underlying the beneficial effects of magnesium supplementation.Clinical Trials Registration ClinicalTrials.gov NCT02837328Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT02837328Funding StatementThis work was supported by internal funds of the Division of Epidemiology and Community Health, University of Minnesota, the McKnight Land-Grant Professorship funds, the American Heart Association grant 16EIA26410001 (Alonso), the National Heart, Lung, And Blood Institute grants T32HL007779 and T32HL007024 (Rooney), the National Center for Advancing Translational Sciences award UL1TR002494. Dr. Alonso was additionally supported by the National Heart, Lung, And Blood Institute of the National Institutes of Health under award number K24HL148521. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are available on request from the corresponding author. The data are not publicly available to safeguard privacy of participants. ER -